Risk of neurological and psychiatric diagnoses in COVID-19 survivors: A multicenter retrospective cohort study using electronic health records

Table 3 Odds ratio for risk of neurological and psychiatric disorders among coronavirus disease 2019 patients

	OR (COVID-19 vs no COVID-19)	95%CI	P value
Neurological disorders
Cognitive deficit			0.0001
Yes	1.54	1.23-1.91
No	Reference1	Reference1
Myoneural junction			0.13
Yes	0.8	0.6-1.07
No	Reference1	Reference1
Ischaemic stroke			0.006
Yes	0.72	0.56-0.91
No	Reference1	Reference1
Nerve plexus disorder			0.02
Yes	1.13	1.01-1.25
No	Reference1	Reference1
Insomnia			< 0.0001
Yes	0.54	0.46-0.63
No	Reference1	Reference1
Parkinsonism			0.002
Yes	0.61	0.44-0.83
No	Reference1	Reference1
Substance use disorder			0.01
Yes	1.95	1.12-3.38
No	Reference1	Reference1
Intracranial hemorrhage			0.0005
Yes	0.59	0.44-0.79
No	Reference1	Reference1
Guillain-Barré syndrome			0.83
Yes	0.93	0.48-1.79
No	Reference1	Reference1
Epilepsy			< 0.0001
Yes	0.79	0.72-0.88
No	Reference1	Reference1
Encephalopathy			0.79
Yes	1.06	0.68-1.65
No	Reference1	Reference1
Dementia			0.23
Yes	1.16	0.91-1.49
No	Reference1	Reference1
Psychiatric disorders
Mood disorder			0.003
Yes	1.16	1.05-1.29
No	Reference1	Reference1
Psychotic disorder			0.09
Yes	0.83	0.67-1.03
No	Reference1	Reference1
Anxiety disorder
Yes	1.39	1.07-1.79	0.01
No	Reference1	Reference1

¹Reference group.

OR: Odds ratio; CI: Confidence interval; COVID-19: Coronavirus disease 2019.